Stay updated with breaking news from Eva Kalias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, November 4, 2022 - Santhera Pharmaceuticals (SIX: SANN) provides an update on its activities and is calling an Extraordinary General Meeting (EGM)
Investegate announcements from Santhera Pharmaceuticals Holdi, European Medicines Agency Validates Santhera’s Marketing Authorization Application for Vamorolone in Duchenne Muscular Dystrophy
Pratteln, Switzerland, October 31, 2022 - Santhera Pharmaceuticals (SIX: SANN) announces that the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for vamorolone
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Announces Half-Year 2022 Financial Results and Provides Corporate Update
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy